In fact, studies have shown that higher levels of NAD(P)H quinone dehydrogenase 1 (NQO1) and NRF2 expression are associated with higher-grade cancers such as endometrial and cervical carcinomas as opposed to healthy tissue and precancerous lesions (Osman et al., 2015). Here, NQO1 is linked to cervical carcinoma.